CDMO News
Teijin Partners with Hilleman Laboratories for Cell and Gene Therapy CDMO Expansion
Teijin Limited and Hilleman Laboratories have announced a strategic collaboration to drive growth in contract development and manufacturing organisation (CDMO) services for cell and gene therapies. The partnership, marked by the recent signing of a Memorandum of Understanding (MoU), will
30 October 2024